Why is this important?
There is growing pressure from patients, healthcare payers, and governments to reduce the environmental impact of life sciences. In the future, we expect new legislation that will require pharmaceutical and contract research organizations to measure and report on the environmental impact of their operations.
The Pistoia Alliance believes that an immediate opportunity is the assessment of the impact that clinical trials have on the environment. Evaluation of the carbon footprint of clinical trials is rarely evaluated despite it being very visible. More pharmaceutical companies are moving towards the model of Decentralized Clinical Trials (DCT) and currently, it is not known if this new approach will have a greater or lesser impact on carbon footprint. A robust and accurate methodology for assessment is needed and will require collaboration amongst a broad mix of experts from both the life sciences and sustainability fields.
What will the project achieve?
We propose to lead a coalition of experts to build a dynamic model that:
- Identifies the key drivers for carbon footprint in a clinical trial and develop metrics for each with estimates of each for a ‘typical’ clinical trial
- Users of the model will have the ability to turn on and off key parameters such as patient engagement, DCT, and patient diversity activities in order to see the impact of each on carbon footprint.
Our Supporters
Thanks to the companies who are making this community possible, without their help this community would not exist or collaborate.
Ready to Get Involved?
There has never been a more important time to collaborate to innovate as an industry! If you would like to find out more about the benefits of Pistoia Alliance membership and how you can get involved with all the different initiatives we run, please send an email to Membership@PistoiaAlliance.org.
